Case reportAnnals of hematologyPublished
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Case report
- Venue
- Annals of hematology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Niacinamide; Pyrazoles; Fusion Proteins, bcr-abl; Protein Kinase Inhibitors; Treatment Outcome; Drug Resistance, Neoplasm; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Cytopenia; Tyrosine Kinase Inhibitors (Tkis); Asciminib; Subtherapeutic Dosing
- PubMed ID
- 40192757
- PubMed Central ID
- PMC12141399
- Open access
- Yes, open
- Added to directory
- Source checked